π UnitedHealth $UNH -1.8% midday β down 18% in 2026 as DOJ probe and rate squeeze grind on
UNH slid ~1.8% Monday, staying deep in the red for 2026 β now down roughly 18% year-to-date. The DOJ antitrust investigation into UnitedHealth's Optum-insurance relationship keeps hanging over the stock, while CMS proposed a near-zero 0.09% Medicare Advantage rate hike that barely covers surging outpatient costs. Medical expense ratios are running hot, squeezing margins across UnitedHealth's massive book of business. Not financial advice. Do you see $UNH as a long-term buying opportunity or a broken story?
β‘ 7 buzzing
160 views
π 0 subscribed